Trial Profile
Improving Outcomes in Fistula Intervention: A prospective, patient blinded, phase 3, randomised controlled trial of Drug Eluting Balloons in the Angioplasty of Native Haemodialysis Access Arteriovenous Fistula Outflow Stenosis (DeVA)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Oct 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders; Restenosis
- Focus Therapeutic Use
- Acronyms DeVA
- 02 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 07 Nov 2018 Planned End Date changed from 29 Oct 2018 to 30 Apr 2020.
- 07 Nov 2018 Status has been changed to recruiting.